Tuberculosis Testing for NTM Patients

Trial Objective

Tuberculosis Testing for NTM PatientsThe purpose of this study is to determine if a new blood test known as the VIDAS Interferon Gamma Release Assay (VIDAS TB-IGRA) is effective at diagnosing tuberculosis (TB) in people with nontuberculous mycobacteria (NTM). The study will evaluate whether nontuberculous mycobacteria interfere with the positive Mycobacterium tuberculosis diagnosis. Researchers are comparing VIDAS TB-IGRA with other diagnostic tests known to accurately detect latent tuberculosis in NTM patients. It is important to rule out a TB infection when treating NTM.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

People with suspected NTM infection based on clinical symptoms and/or early diagnostic evidence may be eligible for this study.

Age: 18+    Gender: Any Gender


Estimated Time Commitment

Up to 2 clinic visits



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Michael White

Michael White
303.398.1417

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

bioMerieux

Principal Investigators

Co-Investigators


Request More Information

Complete this form to learn more about this study and see if you qualify.


*
*
*
*